2012 News

Guglielmo
Faculty retreat, Recent faculty publications: Burlingame, Arkin, Chen, Cocohoba, Bero. Recently received research funding: Yang, Ahituv, Wells, Burlingame. Gifts: John and Marcia Goldman Foundation: The Kidney Project, Harry W. Hind Request: Troy C. Daniels Distinguished Professorship, The Joseph and Vera Long Foundation: Mary Anne Koda-Kimble Seed Award for Innovation. PharmD students: Class of 2012 stats, SNPhA: Chang and Alvarez. PhD students: CCB: Miller and Serafimova.
Roy accepts award.
Shuvo Roy, PhD, will be inducted on November 1st as a member of the BayBio Pantheon for his contributions to the life sciences industry and specifically for work developing the world’s first surgically implantable bioartificial kidney. The BayBio Pantheon, which currently has 52 elected members, honors the achievements of Northern California life scientists.
Roy
The effort to create the first implantable bioartificial kidney has received a $750,000 gift from the John and Marcia Goldman Foundation. Led by UCSF bioengineer Shuvo Roy, PhD, The Kidney Project brings together researchers at nine institutions nationwide. Roy is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine.
Desai
Two years after launching as a pilot effort, an innovative graduate curriculum in translational medicine jointly offered by UCSF and UC Berkeley has received final approval from University of California President Mark Yudof as a master’s degree program.
Birnbaum and daughter Ruth
The lab of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, studies how abnormalities in DNA segments that control the activity of genes could lead to diseases. Recently, researchers there have begun applying that focus to seeking a genetic basis and diagnosis for an epilepsy of early childhood, a disease that hit home for one lab scientist.
Guglielmo
Joseph Guglielmo, PharmD, has been named interim dean of the UCSF School of Pharmacy, and will take the reins of the school from outgoing Dean Mary Anne Koda-Kimble, PharmD, as of July 1. Guglielmo is an internationally recognized expert in the clinical use of antimicrobials and has served as chair of the Department of Clinical Pharmacy since 2006.
Nelson
Sarah Nelson, PhD, was selected by the UCSF Graduate Students Association and Graduate Division Alumni Association as the winner of the 2012 Outstanding Faculty Mentorship Award. Nelson was presented with the award during the Graduate Division commencement on May 18, 2012. She is a co-chair and faculty member of the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine,
Koda-Kimble
Mary Anne Koda-Kimble, PharmD, dean of the UCSF School of Pharmacy, was honored by the UCSF Medical Center on May 4, 2012 for her “exceptional vision as a leader, commitment to patients, compassion as a human being, and dedication to UCSF Medical Center and UCSF Benioff Children’s Hospital.” The leadership award is especially significant, according to Koda-Kimble, “because the Medical Center is at the heart of my career as a pharmacist.”
Hind
Harry W. Hind, a 1939 graduate of the UCSF School of Pharmacy who invented solutions that revolutionized contact lens use, as well as a topical patch to treat pain from shingles, died on April 12 at age 96. Hind co-founded Barnes-Hind Pharmaceuticals Inc., which developed drugs to treat tuberculosis and glaucoma. He was a trustee of the UCSF Foundation and a major benefactor of the School of Pharmacy.
The White House.
Speaking on a White House panel discussing President Obama's just-released Bioeconomy Blueprint, UCSF Vice Chancellor for Research Keith Yamamoto, PhD, cited the implantable bioartificial kidney project led by UCSF bioengineer Shuvo Roy, PhD, as a prime example of biomedical collaboration with potentially major social and economic impact.
New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included a half-dozen on-going projects by BTS faculty: Genetic mutations and liver cancer Xin Chen, PhD Associate adjunct professor Awarded two new grants totaling $351,488 from the National Institute of Alcohol Abuse and Alcoholism (part of a two-year $405,563 grant) and the National Cancer Institute (part of a two-year $369,642 grant)
chart
For the 32nd consecutive year, the UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States. Total grants and contracts awarded to School of Pharmacy researchers during the NIH fiscal year 2011 (running from October 1, 2010 to September 31, 2011) totaled $29.1 million, according to Michael Nordberg, MPA/HSA, associate dean of administration and finance.
Desai
UCSF bioengineer Tejal Desai, PhD, will receive the 2012 Paul R. Dawson Biotechnology Award from the American Association of Colleges of Pharmacy (AACP) at the group’s annual meeting in July.
Roy
The effort led by UCSF bioengineer Shuvo Roy, PhD, to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the U.S. Food and Drug Administration (FDA).
Shoichet
Computational chemist Brian Shoichet, PhD, a faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, is the new director of the California Institute for Quantitative Biosciences (QB3) at UCSF. QB3, with research facilities at UC campuses in San Francisco, Berkeley, and Santa Cruz, has an academic director at each site, as well as a director who oversees operations as a whole.
students in classroom
The UCSF School of Pharmacy continues to rank number 1 among Doctor of Pharmacy (PharmD) programs in the United States, according to a new, 2012 survey published by U.S. News & World Report. The survey results appear in the magazine’s 2013 issue of “American Best Graduate Schools,” which appeared online today at the U.S. News & World Report website and will be available at newsstands on April 3.
Koda-Kimble
Research: growth over past decade from $17.6 to 43.5 million, Apollonio, Roy, Wells, Center for Quantitative Pharmacology, Quantitative Biosciences Consortium. Faculty: DeGrado, Savic, James, Day, Rice, MacDougall, Fischbach, Huang. Students: Hluhanich, Frear, Gavrilova, Gayle, Tantipinichwong, Vuong, Etemadi. New appointments: Nordberg, Rhode. Medical Center: APeX, Brodowy, Laret. Proposal to UC Regents: Desmond-Hellmann, working group. Strategic plan.
Koda-Kimble
Following the UCSF website's announcement of School of Pharmacy Dean Mary Anne Koda-Kimble's June 30, 2012 retirement came comments from leaders at UCSF and beyond. Koda-Kimble, whose 46 years at UCSF began as a PharmD student, became (in 1998) the first female dean of the top-ranked pharmacy school in the nation and the first leader from a clinical background.
UCSF School of Pharmacy Dean Mary Anne Koda-Kimble, PharmD, announced today that she is stepping down as dean and retiring from UCSF on June 30, 2012, after 14 years as dean and 41 years as a member of the faculty. “I am prouder than ever with the accomplishments of our staff, faculty, and students and more energized than ever by the possibilities for the School and UCSF in the coming years…now is an auspicious time for a new and visionary leader.”